Announcements
- IGM Biosciences to Present at the Jefferies Healthcare Conference
- IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
- IGM Biosciences Announces Refocusing of Sanofi Collaboration
- IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
- IGM Biosciences Announces Third Quarter 2023 Financial Results
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.95 |
---|---|
High | 6.10 |
Low | 5.90 |
Bid | 5.55 |
Offer | 6.40 |
Previous close | 6.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | 59.02m |
Free float | 22.06m |
P/E (TTM) | -- |
Market cap | 377.75m USD |
EPS (TTM) | -4.31 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 19:08 BST.
More ▼